4月1日 - ** 基因测试公司Tempus AI TEM.O股价上涨3.56%至46.83美元
** 该公司称，与医疗设备制造商美敦力MDT.N的一项合作研究显示，通过电子健康记录发送的人工智能驱动警报改善了对主动脉瓣狭窄或二尖瓣反流这两种严重心脏瓣膜疾病患者的及时评估和治疗。
** 研究显示，警报组患者接受心脏专科团队评估或瓣膜手术的几率比接受常规治疗的患者高出 27%，达到了主要目标 - TEM
** 在心脏扫描后的 90 天内，警报将瓣膜手术率从 9.6% 提高到 13.4%，专业心脏团队评估率从 17.9% 提高到 22.7% - TEM
** 2025 年，TEM 的股价上涨了 74% 以上。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.